INS and fatty liver disease: Further molecular details will be investigated in future studies, but the molecular changes described herein are consistent with the hypothesis that under HFD, attenuation of pathways downstream of mTORC1 improves both glucose and lipid homeostasis, helps to preserve insulin sensitivity, and results in reduced liver steatosis and improved muscle function.